Systemic therapy for metastatic Renal Cell Carcinoma (mRCC ... one such agent called belzutifan is already approved for VHL-associated RCC and other VHL-associated neoplasms, and a series of trials ...

This is the largest worldwide action aimed at screening for malignant skin neoplasms, surpassing the initiatives of the European community. 2 In addition to actions associated with population health ...